期刊文献+

催乳素及其受体水平与妊娠期糖尿病产妇妊娠结局的相关性 被引量:2

Correlations between prolactin,prolactin receptor levels and pregnancy outcome in puerpera with gestational diabetes mellitus
下载PDF
导出
摘要 目的研究催乳素(PRL)及其受体水平与妊娠期糖尿病(GDM)产妇妊娠结局的相关性。方法回顾性100例GDM产妇的临床资料,按照不良妊娠结局发生情况将其分为不良结局组(发生不良妊娠结局,n=42)和对照组(未发生不良妊娠结局,n=58)。比较2组PRL、胎盘催乳素(HPL)、催乳素受体(PRLR)、空腹血糖(FBG)、胰岛素抵抗指数(HOMA-IR)、餐后2 h血糖(2 hFBG)、糖血红蛋白(HbA1c)水平;采用受试者工作特征(ROC)曲线分析PRL、HPL和PRLR mRNA预测GDM产妇不良妊娠结局的价值;分析PRL、HPL、PRLR mRNA水平与不良妊娠发生率的相关性。结果GDM产妇不良结局发生率为42.00%,主要以巨大儿和胎儿窘迫为主。巨大儿和胎儿窘迫例数分别占不良结局产妇总例数的64.29%、16.67%。不良结局组PRL、HPL和PRLR mRNA水平低于对照组,差异有统计学意义(P<0.05)。PRL、HPL和PRLR mRNA预测GDM产妇不良妊娠结局的曲线下面积分别为0.763、0.855、0.791。PRL、HPL和PRLR mRNA水平与不良妊娠结局发生率呈显著负相关(P<0.05)。结论PRL、HPL和PRLR mRNA水平的异常表达均可能提示GDM产妇不良妊娠结局的发生。 Objective To study the correlations between prolactin(PRL),its receptor level and pregnancy outcome of puerpera with gestational diabetes mellitus(GDM).Methods The clinical data of 100 puerpera with GDM was retrospectively analyzed.According to the occurrence of adverse pregnancy outcomes,they were divided into adverse outcome group(adverse pregnancy outcomes,n=42)and control group(no adverse pregnancy outcomes,n=58).The levels of PRL,placental prolactin(HPL),prolactin receptor(PRLR),fasting blood glucose(FBG)and insulin resistance index(HOMA-IR),2 h postprandial blood glucose(2 hFBG)and glycosylated hemoglobin(HbA1c)were compared between the two groups;receiver operating characteristic(ROC)curve analysis was used to analyze the predictive value of PRL,HPL and PRLR mRNA in GDM maternal adverse pregnancy outcomes;the correlations between PRL,HPL as well as PRLR mRNA levels and the incidence of adverse pregnancy were analyzed.Results The incidence of adverse outcomes of GDM was 42.00%,mainly including macrosomia and fetal distress.The macrosomia and fetal distress accounted for 64.29%and 16.67%of the total cases of adverse outcomes,respectively.The levels of PRL,HPL and PRLR mRNA in the adverse outcome group were significantly lower than those in the control group(P<0.05).The area under the curve of PRL,HPL and PRLR mRNA in predicting adverse pregnancy outcome of GDM puerpera were 0.763,0.855 and 0.791,respectively.The levels of PRL,HPL and PRLR mRNA were significantly negatively correlated with the incidence of adverse pregnancy outcomes(P<0.05).Conclusion Abnormal expression of PRL,HPL and PRLR mRNA levels may indicate the occurrence of adverse pregnancy outcomes in GDM puerpera.
作者 樊菊香 张铭 高燕芳 张文蓉 于运 FAN Juxiang;ZHANG Ming;GAO Yanfang;ZHANG Wenrong;YU Yun(Department of Clinical Laboratory,Changzhou Maternal and Child Health Hospital of Jiangsu Province,Changzhou,Jiangsu,213000)
出处 《实用临床医药杂志》 CAS 2021年第20期111-114,132,共5页 Journal of Clinical Medicine in Practice
基金 江苏省妇幼健康科研重点项目(F201705) 南京医科大学科技发展基金一般项目(NMUB2019321)。
关键词 妊娠期糖尿病 催乳素 胎盘催乳素 胎盘催乳素受体 gestational diabetes mellitus prolactin placental prolactin placental prolactin receptor
  • 相关文献

参考文献12

二级参考文献109

  • 1申彩霞,靳钰,张战红.妊娠期糖尿病胎盘微绒毛形态计量学改变与围产儿并发症关系的探讨[J].现代妇产科进展,2007,16(6):413-416. 被引量:13
  • 2Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 3韩方,杨海澜.妊娠期糖尿病胎盘的病理研究现状[J].中国优生与遗传杂志,2007,15(9):13-14. 被引量:9
  • 4中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 5中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 6International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 7International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 8Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 9Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 10Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.

共引文献1443

同被引文献33

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部